Obamacare's Deadly Disparity

  • by: |
  • 01/02/2013

Previous research has shown that people in states with formularies that limit access to new drugs are more likely to die sooner than those that have access to innovation medications..  So read the following article with that in mind.. 

Will States’ Prescription Drug Essential Health Benefits Be Essentially the Same?

December 14, 2012 By Jenny M. Burke
A new study indicates that basic prescription drug coverage could vary dramatically from state to state as requirements under the Patient Protection and Affordable Care Act (PPACA) (P.L. 111-148) are implemented. Under the new regulations, states have the ability to set minimum mandatory benefits for private health plans that will be offered beginning in January, 2014.
In a study released last week, the market analysis firm Avalere Health found that some states will require coverage of virtually all FDA-approved drugs, while others will only require coverage of about half of medications. Connecticut,Virginia and Arizona will be among the states with the most generous coverage, while California, Minnesota and North Carolina will be among states with the most limited coverage. Consumers in all states will have access to essential medications, but some will have fewer choices than others.
CMS recently released a proposed rule covering the requirements for the essential health benefits under section 1302 of PPACA, including the prescription drug and other benefits, the determination of the actuarial value of the health benefits, and recognition of accreditation agencies that will be responsible for determining whether health plans are qualified. The proposed requirements would apply to non-grandfathered health insurance plans offered in the individual and small group markets beginning January 1, 2014, whether or not they are offered on the health insurance exchange, but not to self-insured plans.

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
Better Health
Biotech Blog
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
Envisioning 2.0
FDA Law Blog
Fierce Pharma
Fresh Air Fund
Furious Seasons
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
In the Pipeline
In Vivo
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
More than Medicine
National Review
Neuroethics & Law
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmacology Corner
Pharmaceutical Business Review
Piper Report
Prescription for a Cure
Public Plan Facts
Real Clear Politics
Shark Report
Shearlings Got Plowed
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog